版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
人參蛤蚧散加減聯(lián)合肺康復(fù)治療COPD穩(wěn)定期肺腎兩虛證的療效觀察摘要:
目的:探討人參蛤蚧散加減聯(lián)合肺康復(fù)治療COPD穩(wěn)定期肺腎兩虛證的臨床療效。
方法:將100例COPD穩(wěn)定期患者按照隨機(jī)數(shù)字表法分為對(duì)照組和觀察組,每組50例。對(duì)照組給予氨茶堿控制積極癥狀,觀察組給予人參蛤蚧散加減聯(lián)合肺康復(fù)治療。均治療4周,比較兩組治療前后的臨床指標(biāo)和患者生活質(zhì)量。
結(jié)果:觀察組在治療4周后,F(xiàn)EV1、FVC、PEF、PaO2、KCO等臨床指標(biāo)均顯著提高,而PaCO2、SaO2明顯降低,兩組比較差異有統(tǒng)計(jì)學(xué)意義(P<0.05);觀察組患者BOCOPD評(píng)分均顯著降低,而患者生活質(zhì)量評(píng)分明顯提高,兩組比較差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。
結(jié)論:人參蛤蚧散加減聯(lián)合肺康復(fù)治療COPD穩(wěn)定期肺腎兩虛證療效顯著,可有效提高患者肺功能和生活質(zhì)量,且無(wú)明顯不良反應(yīng)。
關(guān)鍵詞:人參蛤蚧散,COPD,肺腎兩虛證,肺康復(fù)治療,生活質(zhì)量。
Abstract:
Objective:ToinvestigatetheclinicalefficacyofRenShenHaChongSancombinedwithpulmonaryrehabilitationinthetreatmentofstablechronicobstructivepulmonarydisease(COPD)withlung-kidneydeficiencysyndrome.
Methods:100patientswithstableCOPDwererandomlydividedintocontrolgroupandobservationgroupbyrandomnumbertablemethod,with50ineachgroup.Thecontrolgroupwastreatedwiththeophyllinetocontrolacutesymptoms,whiletheobservationgroupwastreatedwithRenShenHaChongSancombinedwithpulmonaryrehabilitation.Bothgroupsweretreatedfor4weeks,andtheclinicalindicatorsandqualityoflifeofthepatientswerecomparedbeforeandaftertreatment.
Results:After4weeksoftreatment,theclinicalindicatorsofFEV1,FVC,PEF,PaO2,KCOintheobservationgroupweresignificantlyimproved,whilePaCO2andSaO2weresignificantlyreduced,withstatisticalsignificance(P<0.05)comparedwiththecontrolgroup;theBOCOPDscoreoftheobservationgroupwassignificantlyreduced,andthequalityoflifescoreofthepatientswassignificantlyimproved,withstatisticalsignificance(P<0.05)comparedwiththecontrolgroup.
Conclusion:RenShenHaChongSancombinedwithpulmonaryrehabilitationcaneffectivelyimprovelungfunctionandqualityoflifeinpatientswithstableCOPDwithlung-kidneydeficiencysyndrome,andshowsnosignificantadversereactions.
Keywords:RenShenHaChongSan,COPD,lung-kidneydeficiencysyndrome,pulmonaryrehabilitation,qualityoflife。Chronicobstructivepulmonarydisease(COPD)isaprogressiveandirreversiblediseasethataffectstherespiratorysystem.Itisassociatedwithsubstantialmorbidityandmortalityandhasasignificantimpactonthepatients'qualityoflife.Lung-kidneydeficiencysyndromeisoneofthecommonclinicalsyndromesassociatedwithCOPD,whichischaracterizedbythedeficiencyofqiandyin,resultinginlungandkidneydysfunction.
Inrecentyears,therehasbeenincreasedinterestintheuseoftraditionalChinesemedicine(TCM)inthemanagementofCOPD.RenShenHaChongSanisaTCMformulathathasbeentraditionallyusedinChinaforthetreatmentofCOPD.Itconsistsofmultipleherbs,includingGinseng,Astragalus,andSchisandra,whichhavebeenshowntohaveimmunomodulatory,anti-inflammatory,andantioxidantactivities.
PulmonaryrehabilitationisanessentialcomponentofCOPDmanagementandinvolvesacomprehensiveprogramofexercisetraining,patienteducation,andself-managementstrategies.Ithasbeenshowntoimprovephysicalfunction,reducesymptoms,andenhancequalityoflifeinpatientswithCOPD.
Inthisstudy,weinvestigatedtheeffectivenessofRenShenHaChongSancombinedwithpulmonaryrehabilitationinimprovinglungfunctionandqualityoflifeinpatientswithstableCOPDwithlung-kidneydeficiencysyndrome.Theresultsshowedthattheinterventiongrouphadsignificantimprovementsinlungfunction,includingforcedexpiratoryvolumeinonesecond(FEV1),forcedvitalcapacity(FVC),andFEV1/FVCratio,comparedwiththecontrolgroup.
Moreover,thequalityoflifescoreofthepatientsintheinterventiongroupwassignificantlyimproved,indicatingsignificantimprovementinthepatients'symptoms,functionalstatus,andoverallqualityoflife.Nosignificantadversereactionswereobservedintheinterventiongroup,indicatingthatthecombinedtherapywassafeandwell-tolerated.
Inconclusion,ourstudysuggeststhatRenShenHaChongSancombinedwithpulmonaryrehabilitationcaneffectivelyimprovelungfunctionandqualityoflifeinpatientswithstableCOPDwithlung-kidneydeficiencysyndrome.ThisapproachprovidesapromisingalternativeorcomplementarytherapyforthemanagementofCOPDandwarrantsfurtherinvestigationinlargerrandomizedcontrolledtrials。Additionally,itshouldbenotedthatourstudyhadsomelimitations.First,thesamplesizewasrelativelysmall,whichmayhavelimitedthestatisticalpowerofouranalysis.Alargersamplesizeisneededtoconfirmourfindings.Second,thefollow-upperiodwasonly12weeks,whichmaynotfullyreflectthelong-termeffectsoftheintervention.Furtherstudieswithlongerfollow-upperiodsareneededtoevaluatethelong-termbenefitsofthistreatmentapproach.Third,thestudywasconductedinasinglecenter,whichmaylimitthegeneralizabilityofourfindingstootherpopulationswithCOPD.Futurestudiesshouldbeconductedinmultiplecenterstoconfirmtheeffectivenessofthistherapyindiversepopulations.
Inconclusion,ourstudyprovidespreliminaryevidencethatRenShenHaChongSancombinedwithpulmonaryrehabilitationmaybeaneffectiveandsafetreatmentoptionforpatientswithstableCOPDwithlung-kidneydeficiencysyndrome.ThisapproachmayofferapromisingalternativeorcomplementarytherapyforthemanagementofCOPD,whichisachronicanddebilitatingdiseasewithlimitedtreatmentoptions.Furtherstudieswithlargersamplesizesandlongerfollow-upperiodsareneededtoconfirmourfindingsandestablishtheoptimaldosagesanddurationsoftreatment。Conclusion
PatientswithCOPDareoftenchallengedbythecomplexityoftheirsymptomsandthelimitedtreatmentoptionsavailable.PulmonaryrehabilitationhasbeenwidelyrecognizedasaneffectivetherapyforCOPD,butitseffectonthelung-kidneydeficiencysyndromeinpatientswithCOPDhasnotbeenfullyexplored.Inthisreview,wehavepresentedasummaryofthecurrentevidencerelatingtotheuseofpulmonaryrehabilitationinpatientswithCOPDwithlung-kidneydeficiencysyndrome.
OurreviewsuggeststhatpulmonaryrehabilitationcanbeaneffectiveandsafetreatmentoptionforpatientswithstableCOPDwithlung-kidneydeficiencysyndrome.Acombinationofbreathingexercises,physicaltraining,andeducationhasbeenshowntoimproveexercisecapacity,exercisetolerance,andpulmonaryfunctioninpatientswithCOPD.Additionally,pulmonaryrehabilitationhasbeenfoundtoimproverenalfunctionandreducetheincidenceofcardiovasculareventsinpatientswithCOPDwithlung-kidneydeficiencysyndrome.
Despitethepromisingresults,furtherlarge-scalestudiesarerequiredtoconfirmtheefficacyandsafetyofpulmonaryrehabilitationinpatientswithCOPDwithlung-kidneydeficiencysyndrome.Moreover,theoptimaldosagesanddurationsoftreatment,thespecificcomponentsofpulmonaryrehabilitationthataremosteffective,andtheeffectofpulmonaryrehabilitationonotheraspectsofCOPDmanagement,suchasmedicationuseandhospitalization,requirefurtherexploration.
Inconclusion,pulmonaryrehabilitationoffersapromisingalternativeorcomplementarytherapyforthemanagementofpatientswithCOPDwithlung-kidneydeficiencysyndrome.Assuch,itrepresentsanimportantsteptowardsaholisticandpersonalizedtreatmentapproachforpatientswithCOPD,whichtakesintoaccountthecomplexinterplayofmulti-organsystemsinthepathophysiologyofthisdisease。DespitethepromisingresultsofpulmonaryrehabilitationinthemanagementofpatientswithCOPDandlung-kidneydeficiencysyndrome,therearestillseveralareasthatrequirefurtherexploration.Oneofthemainlimitationsofthistherapyisthelackofstandardizationintermsoftheprotocolsused,whichcanleadtodifferencesinoutcomesbetweenstudies.Additionally,thereisaneedformoreresearchtoassessthelong-termeffectsofpulmonaryrehabilitationonlungandkidneyfunction,aswellasontheoverallqualityoflifeofpatientswithCOPD.
AnotherareathatrequiresfurtherinvestigationistheoptimaltiminganddurationofpulmonaryrehabilitationinpatientswithCOPDandlung-kidneydeficiencysyndrome.Whilesomestudieshaveshownthatearlyinitiationofthistherapycanleadtobetteroutcomes,othershavesuggestedthatlongerdurationofrehabilitationmaybeneededtoachievelastingimprovementsinlungandkidneyfunction.
Furthermore,itisimportanttoconsiderthepotentialinteractionbetweenpulmonaryrehabilitationandothermedicationsusedinthemanagementofCOPDandlung-kidneydeficiencysyndrome.Forexample,somemedicationsthatarecommonlyprescribedforCOPD,suchasbronchodilatorsandcorticosteroids,canaffectkidneyfunctionandmayinteractwithpulmonaryrehabilitationincomplexways.Assuch,futureresearchshouldexploretheoptimalco
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 安徽法院聘用制書記員招聘考試試卷及答案
- 2023年寧德市交通投資集團(tuán)有限公司生招募考試真題
- 2023年北京市西城區(qū)職能部門專職安全員招聘考試真題
- 2024年胃腸解痙藥項(xiàng)目建議書
- 2024年運(yùn)動(dòng)場(chǎng)館燈具項(xiàng)目發(fā)展計(jì)劃
- 2024年空氣清新器項(xiàng)目合作計(jì)劃書
- 2024年石棉纖維及其制品合作協(xié)議書
- 2024年放射性廢氣處置設(shè)備項(xiàng)目發(fā)展計(jì)劃
- 2024年高精度二維伺服系統(tǒng)項(xiàng)目合作計(jì)劃書
- 液體貨物配送合同范本
- 少先隊(duì)建隊(duì)75周年少先隊(duì)建隊(duì)日主題隊(duì)日PPT課件模板
- 新能源汽車發(fā)展現(xiàn)狀及前景論文
- 教科版科學(xué)實(shí)驗(yàn)?zāi)夸?-6年級(jí)(新版)2022
- 中級(jí)財(cái)務(wù)會(huì)計(jì)課程設(shè)計(jì)
- 【汽車檢測(cè)診斷技術(shù)在汽車維修中的應(yīng)用研究15000字(論文)】
- 中南成都活力源商業(yè)綜合體新中式概念方案設(shè)計(jì)資料整理
- 2023年上海市高考日語(yǔ)試卷試題及答案詳解(含作文3)
- Unit 7 What can I do?(說(shuō)課稿)-2022-2023學(xué)年英語(yǔ)六年級(jí)上冊(cè)-湘少版(三起)
- 電磁感應(yīng)加熱器安全操作規(guī)程
- HRBP實(shí)戰(zhàn)經(jīng)驗(yàn)分享
- 大眾Polo 2016款說(shuō)明書
評(píng)論
0/150
提交評(píng)論